Alexandria Real Estate Equities Inc  

(Public, NYSE:ARE)   Watch this stock  
Find more results for Joel Richardson�
97.40
+0.57 (0.59%)
Mar 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 96.60 - 97.69
52 week 70.97 - 102.96
Open 97.24
Vol / Avg. 269,236.00/446,968.00
Mkt cap 7.02B
P/E 97.68
Div/yield 0.74/3.04
EPS 1.00
Shares 71.46M
Beta 0.89
Inst. own 105%
Jun 23, 2015
Alexandria Real Estate Equities Inc at Mitsubishi UFJ San Francisco Property REIT Conference Add to calendar
May 29, 2015
Alexandria Real Estate Equities Inc Annual Shareholders Meeting (Estimated) - 2:00PM EDT - Add to calendar
May 4, 2015
Q1 2015 Alexandria Real Estate Equities Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 4, 2015
Alexandria Real Estate Equities Inc at Cowen Health Care Conference
Mar 2, 2015
Alexandria Real Estate Equities Inc at Citi Global Property CEO Conference
Feb 3, 2015
Q4 2014 Alexandria Real Estate Equities Inc Earnings Call
Feb 2, 2015
Q4 2014 Alexandria Real Estate Equities Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -7.08% 13.64%
Operating margin 4.40% 24.47%
EBITD margin - 56.64%
Return on average assets -0.66% 1.27%
Return on average equity -2.06% 2.03%
Employees 243 -
CDP Score - -

Address

385 E Colorado Blvd Ste 299
PASADENA, CA 91101-6104
United States - Map
+1-626-5780777 (Phone)
+1-626-5780896 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alexandria Real Estate Equities, Inc.is a real estate investment trust (REIT). The Company is an owner and REIT, and life science real estate company, focused on science-driven cluster development through the ownership, operation, management, selective acquisition, development, and redevelopment of properties containing life science laboratory space. The Company is a provider of real estate, technical infrastructure, and services to the life science industry. Client tenants include institutional (universities and independent non-profit institutions), pharmaceutical, biotechnology, medical device, product, and service entities and government agencies, , medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies.

Officers and directors

Joel S. Marcus J.D., CPA. Chairman of the Board, President, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Dean A. Shigenaga Chief Financial Officer, Executive Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen A. Richardson Chief Operating Officer, Regional Market Director - San Francisco
Age: 52
Bio & Compensation  - Reuters
Thomas J. Andrews Executive Vice President, Regional Market Director � Greater Boston
Age: 52
Bio & Compensation  - Reuters
Daniel J. Ryan Executive Vice President, Regional Market Director � San Diego and Strategic Operations
Age: 47
Bio & Compensation  - Reuters
Peter M. Moglia Chief Investment Officer
Age: 46
Bio & Compensation  - Reuters
Richard B. Jennings Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
James H. Richardson Director
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John L. Atkins III Independent Director
Age: 70
Bio & Compensation  - Reuters
Maria C. Freire Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters